LEO Pharma

Today, we are celebrating 40 years of the LEO Foundation! 🎉    The LEO Foundation // LEO Fondet is one of the world's largest private funders of independent skin research. Not only does it uphold ownership of #LEOPharma with a strong, purpose-led governance, but it also drives advancements in skin research and care through its commitment to philanthropy. The foundation's unwavering dedication to advancing skin research and care has helped millions of people. Here’s to their continued mission and making a difference for the next 40 years and beyond! 🌟

Today is Earth Overshoot Day – which is marked every year on the day human consumption of natural resources exceeds what nature can regenerate in the year. 🌍 As an organization, #LEOPharma is working towards a more sustainable future with responsible business practices for the benefit of our patients, people and the planet. By optimizing energy efficiency, using renewable energy and transitioning towards a more sustainable car fleet, we successfully reduced our Scope 1 and 2 emissions by 39.2% in 2023, compared to 2019, which means we are on track to reach our 2030 target of reducing our own emissions by more than 50%. By engaging with suppliers and encouraging climate action, it is our ambition to drive impact throughout the value chain. In 2023, 83% of our suppliers by emissions had set their own climate targets or announced commitments to reducing their carbon emissions. At LEO Pharma, we remain committed to advancing the standard of care for those living with dermatological conditions while acting responsibly in everything we do. #DermatologyBeyondTheSkin #EarthOvershootDay

At #LEOPharma, we are committed to advancing the standard of care for people living with skin diseases. Today, we proudly share that new LEO Pharma data is featured in The Lancet – perhaps the most important and prestigious peer-reviewed medical journal. This is a testament to the extraordinary efforts of our colleagues who have worked on these trials. Congratulations to everyone involved! #DermatologyBeyondTheSkin

Did you know that there are more than 3,000 different skin diseases – and that more than 1.8 billion people are affected worldwide? Today is World Skin Health Day. At LEO Pharma, we recognize the importance of this initiative to educate on skin conditions and the importance of skin health. As a company with a long heritage in dermatology, treating more than 95 million patients every year, we are steadfast in our commitment to making a fundamental difference for those who need us most in medical dermatology – and to improving quality of life for the increasing number of people living with skin diseases. Today is about spotlighting the needs and the reality of so many people living with a skin disease. For more insightful facts and testimonies, please visit worldskinday.org. ✨ #WorldSkinHealthDay #LEOPharma #DermatologyBeyondTheSkin 

As Pride month comes to a close and we commemorate the anniversary of the Stonewall Inn Riots, we’ve taken a moment to reflect on our Pride Every Day commitment across LEO Pharma. Hear what our LEO allies from across the business have to say about what this means to us.   Because the month might be ending – but our commitment doesn’t. We're proud of the steps we've taken to honor the LGBTQ+ community and promote inclusivity this month and are more energized than ever to keep going.  We’ll continue to champion inclusion every day, creating a workplace where everyone feels valued, respected and free to show up at work as their true selves each day. #PrideEveryDay #InclusionMatters #LEOPharma

Today, our Head of Medical Excellence & Affiliate Operations, Karin Madsen, addressed attendees of the 6th Annual Global Medical Affairs Summit. Karin discussed significant transformations in medical affairs over recent years, emphasizing the evolving scientific and strategic leadership competencies required to drive this change. She also shared strategies for identifying, shaping and role modeling these competencies – and presented methods for attracting, retaining and developing top medical affairs talent and leaders.   Big thanks to Karin for sharing her unique insights with the medical affairs community today. This is simply critical to delivering innovative therapies to people living with unmet medical needs.   #LEOPharma #DermatologyBeyondTheSkin #MedicalAffairs

🌍 Today is World Environment Day – a fitting occasion to share that all of LEO Pharma’s production sites have transitioned to 100% renewable electricity, demonstrating our dedication to advancing the standard of care while driving sustainable impact. 🌍 Our strategic transition to renewable energy sources has been instrumental in reducing our carbon dioxide emissions. Our journey to full reliance on renewable sources began with our sites in Cork and Dublin (Ireland) in 2019, followed by Ballerup and Esbjerg (Denmark) in 2020 and Segrate (Italy) in 2021 before achieving final completion with our site in Vernouillet (France) earlier this year. This transition is a testament to LEO Pharma’s dedication to leaving a legacy future generations will be proud of. #WorldEnvironmentDay #Sustainability #RenewableEnergy #DermatologyBeyondTheSkin

We are delighted to welcome Dr. Lars Erik Vølund Kristensen, who has joined #LEOPharma as Vice President, Head of External Innovation. Well known for his contributions to the field of immune-mediated inflammatory diseases and with a wealth of experience in business development, scientific #partnerships as well as #innovation, Lars Erik will play a pivotal role in driving strategic partnerships, scouting and securing innovative assets, and identifying new opportunities for growth in line with the company's innovation strategy. In a little over a year, Lars Erik is the third high-profile and internationally recognized professor from the University of Copenhagen to join the team at LEO Pharma, following Professor Jacob Pontoppidan Thyssen, Chief Scientific Officer, and Professor Alexander Egeberg, Vice President, Global Head of Medical Affairs – emphasizing the company’s razor-sharp focus on addressing unmet needs of people living with skin diseases. Lars Erik has also served as an Associate Professor at Lund University in Sweden. He is an internal medicine - rheumatology specialist, holding MD, PhD and DMsci degrees. Additionally, he has held the position of Head of Research at the Parker Institute, Frederiksberg, & Bispebjerg Hospital in the Capital Region of Denmark. #DermatologyBeyondTheSkin

It is #PrideMonth, and at #LEOPharma, we are ringing it in with 'Pride Every Day' 🌈 The theme 'Pride Every Day' reflects our collective belief that support for the #LGBTQ+ Community extends beyond June as a year-round commitment. It is, in fact, integrated in our everyday conduct, fostering a workplace culture that celebrates diversity, promotes inclusion and encourages allyship. LEO Pharma stands in support of the LGBTQ+ community, respecting the values that Pride represents and creating a more inclusive environment. To honor and celebrate the vibrant spirit of this month, we have planned a series of internal events and initiatives that will keep the momentum going throughout the year – with stories and reflections to inspire us beyond June! #DermatologyBeyondTheSkin #PrideCelebration #PrideMonth #DiversityAndInclusion #Allyship

Meet Makiko Watanabe whose strong curiosity and passion for learning about the pharmaceutical industry has resulted in a >12-year-long career as Project Liaison Manager Japan, Global Clinical Development, with LEO Pharma. In her self-presentation (linked to below), Makiko expresses gratitude for LEO Pharma’s inclusive and supportive environment, which celebrates gender equality and female leadership. Read more about Makiko’s career story at https://lnkd.in/dN2H8wn5. Do you want to join our teams working to make a fundamental difference for those who need us most? Then find your next opportunity at https://lnkd.in/eKDCcQ4. #LEOPharma #DermatologyBeyondTheSkin #CareerAtLEO